ERS International Congress 2022: highlights from the Thoracic Oncology Assembly

Abstract

Thoracic malignancies are associated with a substantial public health burden. Lung cancer is the leading cause of cancer related mortality worldwide with significant impact on patients’ quality of life. Following 2 years of virtual annual ERS Congresses due to the COVID-19 pandemic, this year's hybrid ERS Congress in Barcelona, Spain allowed peers from all over the world to meet again and present their work. Thoracic oncology experts presented best practices and latest developments in lung cancer screening, lung cancer diagnosis and management. Early lung cancer diagnosis, subsequent pros and cons of aggressive management, identification and management of systemic treatments’ side effects, the application of artificial intelligence and biomarkers across all aspects of the Thoracic Oncology pathway were among the areas that triggered specific interest and will be summarized here.

ERS International Congress 2023: highlights from the Respiratory Clinical Care and Physiology Assembly

“…In addition to the reports from the other Assemblies [109][110][111][112][113][114][115][116][117][118][119][120][121], we hope that the highlights summarised hereinabove will help update readers with the impressive amount of respiratory research and advances in pulmonary clinical care presented through the sessions from ERS Assembly 1 -Respiratory clinical care and physiology, alongside with suggestions for further investigations. We also hope to have encouraged the readership to contribute to Assembly 1 activities, and to take part to the 2024 ERS International Congress to be held in Vienna next September, where further scientific novelties and clinical developments on these topics will be discussed.…”